Insmed Inc (INSM)
73.15
-0.66
(-0.89%)
USD |
NASDAQ |
Nov 22, 16:00
73.10
-0.05
(-0.07%)
After-Hours: 20:00
Insmed Revenue (Annual): 305.21M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 305.21M |
| December 31, 2022 | 245.36M |
| December 31, 2021 | 188.46M |
| December 31, 2020 | 164.41M |
| December 31, 2019 | 136.47M |
| December 31, 2018 | 9.835M |
| December 31, 2017 | |
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | 11.50M |
| December 31, 2012 | |
| December 31, 2011 | 4.417M |
| Date | Value |
|---|---|
| December 31, 2010 | 6.921M |
| December 31, 2009 | 10.37M |
| December 31, 2008 | 11.70M |
| December 31, 2007 | 7.529M |
| December 31, 2006 | 0.991M |
| December 31, 2005 | 0.131M |
| December 31, 2004 | 0.137M |
| December 31, 2003 | 0.15M |
| December 31, 2002 | 1.955M |
| December 31, 2001 | 0.296M |
| December 31, 2000 | 0.06M |
| December 31, 1999 | 0.001M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
136.47M
Minimum
2019
305.21M
Maximum
2023
207.98M
Average
188.46M
Median
2021
Revenue (Annual) Benchmarks
| Alnylam Pharmaceuticals Inc | 1.828B |
| Amicus Therapeutics Inc | 399.36M |
| Collegium Pharmaceutical Inc | 566.77M |
| enVVeno Medical Corp | -- |
| Fulcrum Therapeutics Inc | 2.805M |